2025911
PR Notice Regarding the New Partner for Delivery Catheter System for Allogeneic iPS Cell-Derived Cardiomyocyte Spheroids
202523
PR Heartseed Announces Enrollment Completion in Phase 1/2 Clinical Trial using HS-001, an Investigational Stem Cell-Derived Therapy for Advanced Heart Failure
2024101
PR Notice Concerning Positive Recommendation from Safety Monitoring Committee for Continuing High-dose Arm in HS-001 Clinical Trial (LAPiS Study)
2024730
PR Heartseed Announces Positive Recommendation from Safety Monitoring Committee for Dose Escalation in Phase 1/2 Clinical Trial Dosed With HS-001
202452
PR Heartseed.'s CFO, Mutsuki Takano, Named "Most Innovative CFO from Asia to Watch in 2024" by CXO Magazine
202449
PR Prof. Massimiliano Gnecchi, Renowned Translational Cardiology Expert, Delivers Lecture at Heartseed.